Akin Soner Amasyali

Akin Soner Amasyali

Auto-generated profile, based on publicly available information

Akin Soner Amasyali

Department of Urology, Loma Linda University Health, Loma Linda, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2018 in Polish Journal of Radiology
Verified
Journal Article
Open access
PDF file
EEErsen Ertekin
Ersen Ertekin
AAAkın Soner Amasyalı
Akın Soner Amasyalı
BEBulent Erol
Bulent Erol
SASaim Acikgozoglu
Saim Acikgozoglu
FKFaruk Kucukdurmaz
Faruk Kucukdurmaz
HEHaluk Erol
Haluk Erol
BACKGROUND:To distinguish RCC subtypes based on contrast enhancement features of CT images. MATERIAL AND METHODS:In total, 59 lesions from 57 patients were included. All patients underwent multi-slice CT imaging with a triphasic protocol, which inclu...

Verified
Journal Article
Open access
PDF file
EAErhan Ates
Erhan Ates
HKHakan Görkem Kazıcı
Hakan Görkem Kazıcı
AAAkin Soner Amasyali
Akin Soner Amasyali
Testicular ischemia and necrosis are quite rare complications following inguinal hernia repair. There is still no consensus on the mechanism of infarction and necrosis in the literature. We present a case with total testicular ischemia and necrosis in the early period following the inguinal hernia repair with prolene mesh, ending up with orchiectomy.

17 April 2024 in Urolithiasis
Verified
Journal Article
Open access
PDF file
AFAla’a Farkouh
Ala’a Farkouh
KPKyu Park
Kyu Park
MBMatthew I. Buell
Matthew I. Buell
NMNicole Mack
Nicole Mack
CGCliff De Guzman
Cliff De Guzman
DBD. Duane Baldwin
D. Duane Baldwin
The purpose of this study was to measure and compare renal pelvic pressure (RPP) between prone and supine percutaneous nephrolithotomy (PCNL) in a benchtop model. Six identical silicone kidney models were placed into anatomically correct prone or supine torsos constructed from patient CT scans in the corresponding positions. A 30-Fr renal access sheath was placed in either the upper, middle, or lower pole calyx for both prone and supine positions. Two 9-mm BegoStones were placed in the respective calyx and RPPs were measured at baseline, irrigating with a rigid nephroscope, and irrigating with a flexible nephroscope. Five trials were conducted for each access in both prone and supine positions. The average baseline RPP in the prone position was significantly higher than the supine position (9.1 vs 2.7 mmHg; p < 0.001). Similarly, the average RPP in prone was significantly higher than supine when using both the rigid and flexible nephroscopes. When comparing RPPs for upper, middle, and lower pole access sites, there was no significant difference in pressures in either prone or supine positions (p > 0.05 for all). Overall, when combining all pressures at baseline and with irrigation, with all access sites and types of scopes, the mean RPP was significantly higher in the prone position compared to the supine position (14.0 vs 3.2 mmHg; p < 0.001). RPPs were significantly higher in the prone position compared to the supine position in all conditions tested. These differences in RPPs between prone and supine PCNL could in part explain the different clinical outcomes, including postoperative fever and stone-free rates.

1 January 2021 in Urology Research and Practice
Verified
Journal Article
Closed access
AFAshley Feldkamp
Ashley Feldkamp
AAAkın S. Amasyalı
Akın S. Amasyalı
JGJason Groegler
Jason Groegler
FJForrest Jellison
Forrest Jellison
ASAndrea Staack
Andrea Staack
Objective: Sacral neuromodulation (SNM) is an advanced treatment option for patients with refractory overactive bladder (OAB) symptoms, urinary retention, and bowel disorders; it is usually performed in 2 separate procedures. This study aims to determine a cohort’s progression rate from stage 1 to 2 and predict factors for progression and unplanned device removal or revision. Material and methods: A retrospective review was conducted in patients who underwent SNM at a single institution between June 2012 and May 2019. Progression rates from stage 1 to 2, patient characteristics, and indications for unplanned SNM removal or revision were recorded. Chi-square, Mann-Whitney U, and Fisher’s exact tests were used for data analysis. Results: A total of 128 patients underwent SNM for 1 or more of the following diagnoses: OAB (n=103), urinary retention (n=15), neurogenic bladder dysfunction (n=4), fecal incontinence (n=2), and constipation (n=4). The progression rate to stage 2 was 92.2% (118/128). Patients who failed to progress to stage 2 had additional diagnoses other than OAB, such as urinary retention or bowel disorders (p=0.007). Fifteen patients (12.7%) required SNM removal or revision within 4 years of surgery. Among these patients, the body mass index was significantly lower (p=0.036). Conclusion: Most patients (92.2%) progressed to stage 2. Patients with only OAB symptoms had a higher progression rate to stage 2. Single full-stage procedures may be considered in select patients to reduce morbidity, time, and costs. Cite this article as: Feldkamp A, Amasyalı AS, Groegler J, Jellison F, Staack A. Evaluation of progression from first to second stage sacral neuromodulation and unplanned device removal. Turk J Urol 2021; 47(1): 58-65.

15 September 2015
Verified
Journal Article
Closed access
AAAkin Soner Amasyali
Akin Soner Amasyali
AAAbdullah Akkurt
Abdullah Akkurt
EKErcan Kazan
Ercan Kazan
MYMustafa Yilmaz
Mustafa Yilmaz
BEBulent Erol
Bulent Erol
HEHaluk Erol
Haluk Erol

1 January 2018 in Urology Annals
Verified
Journal Article
Open access
PDF file
AAAkın Soner Amasyali
Akın Soner Amasyali
UYUğur Yücetaş
Uğur Yücetaş
EEErkan Erkan
Erkan Erkan
MDMurat Demiray
Murat Demiray
EKEmre Karabay
Emre Karabay
EÜErdinç Ünlüer
Erdinç Ünlüer
Background: We investigated the correlation between the sampled number of cores in rebiopsy and the cancer detection rate (CDR). Materials and Methods: Two hundred and twelve patients with normal rectal examination who had undergone rebiopsy in the past 5 years were examined retrospectively. Moreover, 68% of them had undergone 12 cores (Group 1) while 32% had undergone 20 cores (Group 2). Both groups were compared with respect to the CDR. Results: There was no difference between groups in terms of age, total prostate-specific antigen, and prostate volume (P > 0.05). Forty-one (19%) of 212 patients were diagnosed with cancer, and the CDR was significantly higher in Group 2 (30.9% vs. 13.9%, P = 0.004). This rate increased from 6.5% to 20% (P = 0.025) and from 0% to 33.3% (P = 0.023), respectively, with 12-core and 20-core rebiopsies in patients whose initial pathology indicated benign and high-grade prostatic intraepithelial neoplasia (HGPIN). Furthermore, cancer was detected in 24 (40%) of 60 patients who were diagnosed with atypical small acinar proliferation (ASAP) in the initial biopsy. However, despite being higher in 20-core biopsy group (47.6% vs. 35.9%), this was not statistically significant (P = 0.377). Conclusions: At least 20 cores should be sampled in rebiopsy, especially in the patients diagnosed with benign and HGPIN. However, we believe that standard systematic sampling will be sufficient for the patients diagnosed with ASAP.